In addition to its role in tumor antigen presentation and CD8+ T cell priming, cDC1 was also shown to directly regulate CD8+ T cell functions and promote anti-PD-1 therapeutic efficacy through alternative mechanisms. This evidence concerns the gene MPPE1 and neoplasm.